Aug 10, 2017
26:25
For every 25 shares held, investors received 26. The price per share adjusted from $38.95 to $37.45.
The split itself did not change the total investment value.
Scinopharm Taiwan, Ltd. (TWSE:1789) operates in the Biotechnology industry.
Scinopharm Taiwan, Ltd. company overviewScinopharm Taiwan, Ltd.'s most recent stock split was on August 10, 2017. It was a 26-for-25 forward split, so shareholders received 26 shares for every 25 they held.
Scinopharm Taiwan, Ltd. (TWSE:1789) has split its stock 6 times: a 103-for-100 split on August 9, 2012, a 26-for-25 split on August 8, 2013, a 26-for-25 split on August 7, 2014, a 26-for-25 split on August 6, 2015, a 26-for-25 split on August 10, 2016, and a 26-for-25 split on August 10, 2017.
Scinopharm Taiwan, Ltd. has split its stock 6 times. This history records 6 forward splits between August 9, 2012 and August 10, 2017.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Scinopharm Taiwan, Ltd.'s 26-for-25 split on August 10, 2017, every 25 shares became 26 shares.
Scinopharm Taiwan, Ltd. has not announced a new split in our records. Its most recent split was on August 10, 2017, 9 years ago. Companies announce splits in advance, and any new TWSE:1789 split will appear on this page.
Already premium?